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Abstract 
Postconditioning (PostC) can be obtained either with brief cycles of ischemia/reperfusion (I-
PostC) or with a direct targeting of mitochondria with Diazoxide (pharmacological PostC, P-
PostC). I-PostC may induce the activation of RISK and SAFE pathways and may favor nitric 
oxide production with S-Nitrosylation of proteins and redox signaling. It is not clear whether 
Diazoxide can lead to similar effects. We compared the effects of I-PostC and P-PostC on a) 
kinases of RISK- and SAFE-pathway, b) S-Nitrosylation of mitochondrial proteins and c) 
reduction of death signals (PKCδ, cleaved-caspase3 and Beclin-1) in cytosolic and mitochondrial 
fractions. Isolated rat hearts, underwent 1) perfusion without ischemia (Sham), 2) 
ischemia/reperfusion (30-min ischemia plus 2-hours reperfusion), 3) I-PostC (5 intermittent 
cycles of 10-s reperfusion and 10-s ischemia immediately after the 30-min ischemia), 4) P-PostC 
(Diazoxide 30 µM in the first of 3-min of reperfusion) or 5) I-PostC+MPG or P-PostC+MPG 
(MPG, 2-mercaptopropionylglycine 300 µM). Using Western blot and biotin switch assay, we 
found that P-PostC induced a redox sensible phosphorylation/translocation of Akt, ERK1/2 and 
GSK3β into the mitochondria, but not of phospho-STAT3, which was translocated into the 
mitochondria by I-PostC only. Either I-PostC or P-PostC increased mitochondrial S-Nitrosylated 
proteins (e.g., VDAC) and reduced the levels of phospho-PKCδ, cleaved-caspase3 and Beclin-1. 
Therefore, direct targeting of mitochondria with Diazoxide a) activates the RISK-pathway via a 
redox signaling, b) favors discrete mitochondrial protein S-Nitrosylation, including VDAC and c) 
decreases signals of death. Intriguingly, phospho-STAT3 translocation is induced by I-PostC, but 
not by P-PostC, thus suggesting a redox-independent mechanism in the SAFE-pathway. 
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Introduction 
Reperfusion is the only way to salvage an ischemic organ, but it is a double-edged sword and can 
induce severe and irreversible damages to the myocardium, collectively referred to as reperfusion 
injury [42,76,88]. Cycles of brief reperfusion and ischemia performed immediately at the onset of 
reperfusion following a prolonged ischemic insult markedly limits reperfusion injury. This 
cardioprotective phenomenon is named Ischemic Postconditioning (I-PostC), which is as 
powerful as ischemic preconditioning [89]. I-PostC may limit all forms of cell death induced by 
ischemia and reperfusion (I/R) [20,21,41,44,72].  
It is known that I-PostC induces the activation of Reperfusion Injury Salvage Kinase (RISK) and 
Survivor Activating Factor Enhancement (SAFE) pathways [33,34,40,75], with a potential 
dependence of signaling on species and models [77,78]. While the SAFE pathway recognizes 
STAT3 activation as a central point, the RISK pathway includes the activation/phosphorylation of 
several kinases (e.g., Akt, ERK1/2, GSK3β) [33,34,79]. Nevertheless, both pathways converge on 
mitochondria influencing their function. In particular, in the mitochondria, cardioprotective 
pathways lead to the opening of mitochondrial KATP dependent (mitoKATP) and closure of 
mitochondrial transition pore (mPTP) with consequent integrity of these organelles [9,35,67,70]. 
mitoKATP channel activation may be involved in the production of small quantity of reactive 
oxygen species (ROS), which helps to preserve integrity and proper functioning of mitochondria 
themselves [1,14,24,62,66,70]. In fact, like preconditioning, PostC depends on ROS signaling 
[25,69,84]. The I-PostC maneuvers also induce the production of nitric oxide (NO.) and reactive 
nitrogen species (RNS) [69], which can lead to mitochondrial proteins S-Nitrosylation (SNO) 
[25,68,80-83]. Then ROS/RNS in turn lead to the activation of survival kinases such as MAP 
kinases, tyrosine kinases and PKCs, including PKCε and PKCδ, which may have opposing roles 
[12,15,16,31,36,45,58,62]. 
Therefore cardioprotective stimuli starting from outside the mitochondria converge on these 
organelles and then reverberate in the cytosol again. Specifically, I-PostC leads to the 
translocation/phosphorylation of effectors of the RISK and SAFE pathways to the mitochondria, 
then signals from mitochondria affects cytosolic elements again [7,19,33,34,62,66]. 
A protection similar to that obtained with I-PostC has been obtained with pharmacological agents 
given in early reperfusion, referred to as Pharmacological PostC (P-PostC). Many of these 
pharmacological treatments target directly mitochondria [17,33,46]. Recently, we have 
demonstrated that the infusion of Diazoxide, a direct and selective opener of mitoKATP channels, 
induces cardioprotection when infused in the initial three min of reperfusion [65]. Diazoxide 
mediated cardioprotection requires a ROS signaling, both in ischemic pre- and post-conditioning 
[27,65]. Most notable, preconditioning with Diazoxide can increase NO. bioavailability [4] and 
protein translocation [4,27,51]. 
Therefore, we hypothesized that P-PostC with Diazoxide includes SNO-proteins and a ROS 
signaling that triggers a cross talk between mitochondria and cytosol, with consequent 
translocation of cardioprotective factors from cytosol to mitochondria. 
Also when the ischemic heart is reperfused in the absence of any cardioprotective maneuvers, a 
cross-talk between cytosol and mitochondria is responsible for the activation of several 
mechanisms which favor the development of “signals of death” leading to oncosis, apoptosis 
and/or autophagy [54,64,66]. Among these, a role is played by PKCδ translocation within 
mitochondria, where it induces several metabolic modifications, increases mitochondrial ROS-
stress, and promotes apoptosis [16]. Importantly, both I-PostC and some P-PostC reduce some of 
these signals of death [67,81]. To the best of our knowledge there are no studies on the effects of 
P-PostC with Diazoxide on signals of death. 
Our study was aimed to compare the effects of two different types of postconditioning (I-PostC 
and P-PostC, which target indirectly and directly mitochondria, respectively) in terms of 1) kinase 
phosphorylation and translocation, 2) amount of nitrosylated proteins, and 3) modification of 
“signals of death” in mitochondrial fractions obtained from reperfused hearts. 
Materials and Methods 
Animals 
Male Wistar rats (5-6 month old, body weight 450–550 g) were purchased from Janvier (Le 
Genest-St-Isle, France). Animals received humane care in compliance with Italian law (DL-116, 
Jan. 27, 1992) and in accordance with the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). 
Perfusion technique 
Methods used were similar to those previously described [61,63,65,69]. In brief, isolated rat 
hearts were retrogradely perfused at constant flow (9±1 ml/min/g) with oxygenated Krebs–
Henseleit buffer (127 mM NaCl, 17.7 mM NaHCO3, 5.1 mM KCl, 1.5 mM CaCl2, 1.26 mM 
MgCl2, 11 mM D-glucose (Sigma-Aldrich, St. Louis, MO, USA) gassed with 95% O2 and 5% 
CO2 [61,63,65,69]. Hearts were paced at 280 bpm and kept in a temperature-controlled chamber 
(37°C). Coronary perfusion pressure and left ventricular pressure were monitored to assess the 
preparation conditions. 
Experimental protocols 
Infarct size groups 
After the stabilization period, hearts were randomly divided in three groups (n=6 for each group): 
1) I/R group, hearts underwent 30-min of global ischemia and then a period of 120-min full 
reperfusion; 2) I-PostC group, after 30-min ischemia, hearts underwent a PostC protocol (5 cycles 
of 10-s reperfusion and 10-s global ischemia) then a period of 120-min full reperfusion 
[63,65,69]; 3) P-PostC group, after 30-min ischemia, hearts were infused with Diazoxide (30 µM) 
[27,32,65] for 3-min and then underwent a period of 120-min full reperfusion. 
In two additional groups of hearts (P-PostC+MPG and I-PostC+MPG; n= 5 for each group), the 
mitochondrial specific antioxidant, 2-mercaptopropionylglycine (MPG, 300 µM), was co-infused 
with Diazoxide (30 µM) or during I-PostC maneuvers, in the initial 3-min of 120-min reperfusion, 
in order to verify the role of redox signaling [27,65 and references therein]. 
 Assessment of myocardial injury 
Infarct areas were assessed at the end of the experiments with the nitro-blu-tetrazolium technique 
(Sigma-Aldrich, St. Louis, MO, USA) in a blinded fashion, as previously described [61,63,65,69]. 
In brief, immediately after reperfusion hearts were rapidly removed from the perfusion apparatus 
and the left ventricle dissected into 2–3 mm circumferential slices. Following 20-min of 
incubation at 37°C in 0.1% solution of nitro-blue tetrazolium in phosphate buffer, unstained 
necrotic tissue was carefully separated from stained viable tissue by an independent observer, 
who was unaware of the protocols. The necrotic mass was expressed as a percentage of risk area 
(i.e., total left ventricular mass). 
Western blotting and S-Nitrosylation 
 Isolation of rat heart mitochondria 
Seven additional groups of hearts were used to separate the mitochondrial and cytosolic fractions: 
five experimental groups (n= 6 for each Group) are similar to those used for the evaluation of 
infarct size; the other two groups are 1) a Sham (non-ischemic) group in which hearts underwent 
80-min buffer-perfusion only (n=6; Sham group) and 2) a non-ischemic group, in which, for 
comparative purpose, Diazoxide (DZO) was infused for 3-min after the stabilization period (n= 4; 
Sham+DZO group). Mitochondrial and cytosolic fractions were obtained by a modification of 
published procedures [3,10]. In brief, the left ventricle was quickly submerged in 250 mM 
mannitol, 0.5 mM EGTA, 5 mM HEPES, and 0.1% (w/v) BSA (pH 7.4). The tissue was finely 
minced with scissors and then homogenized in the same buffer (10 ml buffer per g tissue), using 
an ice-cold Potter. Large cell debris (membrane and nuclear fractions) were pelleted by 
centrifuging the homogenate twice for 5-min at 600 g and discarded avoiding solubilization of 
membrane proteins. Mitochondria were pelleted by 10-min centrifugation at 10,300 g. The 
supernatant was centrifuged for 1 h at 100,000 g to obtain cytosolic fraction. The mitochondrial 
pellet was suspended, loaded in tubes containing 30% (v/v) Percoll in 225 mM mannitol, 1 mM 
EGTA, 25 mM HEPES, 0.1% (w/v) BSA (pH 7.4) and spun for 30-min at 95,000 g in a Beckman 
Coulter centrifuge with SW40 rotor. Mitochondria were collected from the lower part of the 
dense, brownish yellow mitochondrial band [67]. Protein level in each fraction was determined by 
Bradford's method [11]. 
 Western blotting  
About 50 µg of protein extracts were separated by SDS-PAGE on 8% [for Na+/K+ ATPase, 
PKCδ, phospho-PKCδ, STAT3, phospho-STAT3, vinculin, mitochondrial trifunctional enzyme α 
subunit (HADHA)] 10% [for HSP60, voltage-dependent anion-selective channel (VDAC), protein 
disulfide isomerase (PDI), Lamin A/C, Akt, phospho-Akt, GSK3β, phospho-GSK3β, Beclin-1] or 
12% [for Phospholamban (PLN) and cleaved caspase-3] gels and transferred to PVDF membrane 
(GE Healthcare, Buckinghamshire, UK). The membranes were incubated overnight with the 
following primary antibodies: anti- Na+/K+ ATPase α1 (Upstate Biotechnology, Billerica, MA, 
USA ), anti ERK1/2, anti-phospho-(Thr-202/Tyr-204)-ERK1/2; anti-PKCδ, anti-phospho-(Ser-
643)-PKCδ, anti-Akt, anti-pospho-(Ser-473)-Akt, anti-GSK3β, anti-phospho-(Ser-9)-GSK3β, 
anti-cleaved-caspase-3, anti-phospho-(Ser-727)-STAT3, anti-phospho-(Tyr-705)-STAT3 (Cell 
Signaling Technology, Beverly, MA, USA), anti-Beclin-1 (Sigma-Aldrich, St. Louis, MO, USA), 
anti-HSP60 (BD Biosciences, Franklin Lakes, NJ, USA), anti-Lamin A/C and anti-PLN (Santa 
Cruz Biotechnology, Santa Cruz, CA, U.S.A.), anti-VDAC and anti-PDI (Abcam, Cambridge, 
UK) all were diluted according to the manufacturer's instructions. Immunoblotted proteins were 
visualized by using Immuno-Star HRP Substrate Kit (Bio-Rad Laboratories, Hercules, CA, USA) 
and quantified by Kodak Image Station 440CF. To confirm equal protein loading, blots were 
stripped with 0.4 M NaOH and then re-blotted for all antibodies as well as for anti-vinculin 
antibody (Sigma-Aldrich, St. Louis, MO, USA) or for anti-HADHA (Abcam, Cambridge, UK) 
for cytosolic and mitochondrial fractions, respectively. Image analyses were performed by the 
Kodak 1D 3.5 software [67]. 
 Biotin switch assay for the detection of S-Nitrosylated proteins 
All preparative procedures were performed in the dark (covering all equipments with aluminum 
foil) to prevent light-induced cleavage of nitrosylations [2,47,68,82,86]. Mitochondrial fractions 
were incubated and centrifuged on ice in appropriate buffers (20 mmol l−1 Tris pH 7.5, 150 mmol 
l−1 NaCl, 1% Igepal CA 630, 0.5% Sodium Deoxycholate, 1 mmol l−1 EDTA, 0.1% SDS, 200 
mmol l−1 Sodium Orthovanadate, and Protease Inhibitor Cocktail (Sigma-Aldrich, St. Louis, MO, 
USA). Proteins were quantified with Bradford’s method [11], and the biotin switch assay with or 
without ascorbate (1mM) was performed as previously described [2,47,68]. In particular, blocking 
buffer (225 mmol l−1 HEPES, pH 7.7, 0.9 mmol l−1 EDTA, 0.09 mmol l−1 neocuproine, 2.5% 
SDS, and 20 mmol l−1 MMTS) and HENS buffer (250 mmol l−1 HEPES, pH 7.7, 1 mmol l−1 
EDTA, 0.1 mmol l−1 neocuproine, and 1% SDS) were used (Sigma-Aldrich, St. Louis, MO, USA) 
[2,47,68]. 
To detect biotinylated proteins by Western blot, samples from the biotin switch assay were 
separated on 12% SDS-PAGE gels, transferred to PVDF membranes (GE Healthcare, 
Buckinghamshire, UK), blocked with non-fat dried milk (Santa Cruz Biotechnology, Santa Cruz, 
CA, U.S.A.), and incubated with streptavidin-peroxidase, diluted 1/10000 for 1 h. To confirm 
equal protein loading, blots were stripped with 0.4 M NaOH and then re-blotted with an anti-
vinculin antibody (Sigma-Aldrich, St. Louis, MO, USA). Image analyses were performed by the 
Kodak 1D 3.5 software [67,68]. Since VDAC has a cysteine residue that can be nitrosylated 
[4,57], we assessed VDAC S-Nitrosylation, using the SNO specific protein method adopted by 
several authors [2,26,60,75,82,86], including us [68]. 
.Statistical analysis 
All values are expressed as mean±SE. Data were analyzed using one-way or two-way analysis of 
variance (ANOVA) followed by Bonferroni's post test. p Value≤0.05 was considered to be 
significant. 
Results 
Infarct size (Fig 1) 
Total infarct size, expressed as a percentage of left ventricular mass, was 63±2% in I/R Group. In 
I-PostC, infarct size was significantly lower, 29±2% (p<0.01 vs I/R group). Similar results were 
obtained with P-PostC (Diazoxide infusion), with a significant reduction of infarct size with 
respect to I/R group (34±6%, p<0.05 vs I/R; NS, not significant vs I-PostC). As previously 
reported [18,65,84], the protective effects of I-PostC or P-PostC (Diazoxide infusion) were 
abolished by the infusion of the antioxidant MPG at the beginning of reperfusion. 
Western blotting  
Marker/protein levels were studied by Western-blot analysis in cytosolic and mitochondrial 
fractions. Representative bands and densitometric analysis of the scanned blots are presented in 
all the following figures. Data are normalized with respect to the mean value of the Sham group, 
including the raw data of Sham.  
The integrity and purity of mitochondrial fraction (Fig 2) 
To study mitochondrial integrity we assessed the levels of HSP60 (Fig 2A) [30]; to study the 
purity of mitochondrial (MF) we verified the presence of Na+/K+ ATPase, VDAC, Lamin A/C, 
PLN, PDI and vinculin (Fig 2B) [6,9,13,46,53,60,71], in both MF and cytosolic fraction (CF) 
extracted from non-ischemic (Sham), post-ischemic (I/R) and postconditioned (I-PostC and P-
PostC) hearts. 
As expected, levels of HSP60 were lower in CF than in MF in the Sham group (see bands in Fig 
2A). However, the densitometry revealed that in I/R group the levels of HSP60 decreased in the 
MF and increased in the CF (p<0.05 vs all other groups for both fractions, Fig 2A). Since both I-
PostC and P-PostC maneuvers kept HSP60 levels similar to those of Sham group in both CF and 
MF, it may be inferred that these maneuvers preserved mitochondrial integrity. These results are 
in agreement with those obtained in our previous study [67]. 
As expected, VDAC, a typical protein of mitochondrial membrane, was found in the MF and was 
undetectable in the CF. Yet, the levels of Na+/K+ ATPase, PLN and Lamin A/C, typical proteins 
of cellular membrane, sarcoplasmatic reticulum and nucleus, respectively, were undetectable in 
the MF and present in the remaining fraction, in all experimental groups. Together, these results 
suggest that our MF was substantially free of contaminants. 
However, PDI and vinculin, which are considered typical of the endoplasmic reticulum and 
cytoskeleton, respectively, are present in both CF and MF. These findings are in agreement with 
the observations of several authors for endoplasmic proteins, including PDI [48,53], and for 
cytoskeletal proteins, such as tubulin and vinculin [13,60]. Nevertheless, the absence of nuclear 
proteins in the MF is a prerequisite for the assessment of STAT3 in the SAFE pathway 
[9,34,49,79].  
P-PostC induced a redox dependent translocation to mitochondria of phosphorylated kinases of 
the RISK pathway (Figs 3-5) 
Akt, ERK1/2 and GSK3β are important cardioprotective kinases of the RISK pathway in 
postconditioning [33,34,79]. Here we analyzed the role of ROS signaling in P-PostC induced 
mitochondrial translocation of these kinases.  
Levels of Akt are reported in Fig 3. Of note, an elevated phospho/total ratio was observed in the 
two protected groups (p<0.05 vs Sham and I/R groups for both PostC protocols). Moreover, the 
ROS scavenger, MPG, avoided P-PostC-induced Akt phosphorylation in mitochondrial fraction. 
As can be seen in Fig 4, also the levels of phospho-ERK1/2 are significantly higher in the two 
protected groups (p<0.05 vs Sham and I/R Group for both PostC protocols). Again, MPG avoided 
P-PostC-induced ERK1/2 phosphorylation within mitochondria. 
Levels of GSK3β are reported in Fig 5. The phospho/total ratio of GSK3β resulted significantly 
lower in I/R group (p<0.05 vs Sham), while was significantly higher in the two protected groups 
(p<0.05 vs Sham and I/R Group for the two PostC protocols). Yet, the antioxidant, MPG, limited 
P-PostC-induced GSK3β phosphorylation in mitochondrial fraction. 
As expected, phosphorylated forms of Akt, ERK1/2 and GSK3β were increased in the cytosolic 
fraction by both PostC protocols (data not shown). 
SAFE pathways: only I-PostC induced a significant increase of phospho-STAT3 within 
mitochondria (Fig 6). 
STAT3 is one of the major players of the protective SAFE pathway [9,34,43] and it has been 
reported that in protected hearts its phosphorylation is necessary for a mitochondrial localization 
[34,85]. Therefore, to evaluate the activation of the SAFE pathway, phosphorylation of STAT3 on 
both Ser727and Tyr705 were studied within mitochondria (Fig 6). While I-PostC induced a 
significant increase of both phospho-STAT3 within mitochondria (p< 0.005 vs all other groups), 
P-PostC with Diazoxide was unable to induce a similar effect. 
I-PostC and P-PostC can increase the S-Nitrosylation of mitochondrial proteins (Fig 7) 
Nitric oxide has been shown to be an important mediator of cardioprotection and the addition of 
an NO. group to a protein thiol is known as S-Nitrosylation (SNO) [62]. As can be seen in Fig 7, 
either I-PostC or P-PostC with Diazoxide increased SNO proteins total levels with respect to I/R 
group. Diazoxide given to Sham hearts induced the highest level of SNO proteins, including 
VDAC S-Nitrosylation. Importantly, the levels of nitrosylated VDAC are higher in 
postconditioned hearts than in Sham and I/R groups. 
I-PostC and P-PostC could reduce the “signals of death”(Fig 8)  
As expected, I/R significantly (p<0.01) raised all the signals of death with respect to Sham. The 
two cardioprotective protocols limited these increases, and maintained Sham levels for all the 
enzymes (Fig 8 panels A,C,D), with the exception of mitochondrial PKCδ levels (Fig 8, panel B), 
which were also reduced by the two protective protocols, but not to Sham level by P-PostC (p< 
0.05 P-PostC vs Sham). 
Discussion 
Here we demonstrate, for the first time, that P-PostC cardioprotection with Diazoxide leads to the 
phosphorylation and translocation of kinases of RISK pathway to the mitochondria. This 
translocation is similar to what seen for preconditioning by many authors for both Diazoxide- and 
ischemic-preconditioning [4,32,56,75]. As far as we know, kinase translocation within 
mitochondria after I-PostC has been demonstrated by few authors [7,10]. Here we also 
demonstrate that I-PostC and P-PostC with Diazoxide induce a similar increase in S-Nitrosylation 
of mitochondrial proteins. Among these proteins, we detected S-Nitrosylation of VDAC, which, 
in fact, has a cysteine residue that can be nitrosylated and may play a critical role in the 
mitochondrial permeability transition pore formation [4,35,38,57,60].  
However, differently from I-PostC, P-PostC does not induce STAT3 mitochondrial 
phosphorylation. Since MPG avoids translocation of RISK elements induced by P-PostC, we 
suggest that the redox signaling activated by Diazoxide affects RISK- but not SAFE-pathway. 
Finally, either I-PostC or P-PostC reduces the activation of signals of death caused by I/R. 
S-Nitrosylation (SNO): Nitric oxide is reported to increase SNO of different mitochondrial 
targets [29]. Protein SNO is a redox-reversible posttranslational protein modification which may 
play an important cardioprotective role in PostC maneuvers. For example, NO. increases SNO of 
complex I thereby reducing (not abolishing) ROS generation. SNO also inhibits complex V and 
blocks irreversible oxidation of proteins [29,62]. In addition to I-PostC, also estrogen-induced 
increase in contractility has been shown to involve an increase of SNO of several proteins and an 
upregulation of cardiac eNOS and nNOS [82].  
Importantly, RISK activation in PostC results in NOS activation [33,34,79] thereby explaining 
increased SNO of proteins by I-PostC and indirectly by P-PostC with Diazoxide. Intriguingly, the 
SNO of mitochondrial proteins, including VDAC, is particularly evident when Diazoxide is given 
to non-ischemic hearts (Fig 7); thus suggesting that Diazoxide increases NO formation and favors 
S-Nitrosylation. Actually, it has been reported that Diazoxide increases the levels of 
dimethylarginine dimethylaminohydrolase (DDAH) [51]. Since DDAH metabolizes asymmetric 
dimethylarginine (an endogenous NOS inhibitor), Diazoxide might increase NO. availability and 
SNO via the intervention of DDAH [23]. This deserves to be further studied.  
RISK and SAFE pathways: Protective signaling molecules of RISK and SAFE are activated in 
response to stress to prevent cell death [33,34,79]. Our present results demonstrate that redox-
dependent signals can start from mitochondria (Diazoxide effect) to modulate RISK, but not 
SAFE elements. Previous studies have suggested an essential role for ROS signaling in PostC 
protection [25,69,84], but, to the best of our knowledge, no one has studied the role of RISK and 
SAFE in P-PostC with Diazoxide, a drug supposed to promote ROS signaling through actions on 
mitoKATP channels, with the contribution of mitochondrial connexin-43 [7,10,37,71,73]. 
RISK: Akt and ERK1/2 are reported to phosphorylate and inhibit GSK3β resulting in 
cardioprotection via multiple targets within mitochondria [33,34]. 
Akt can translocate to subcellular compartments including the nucleus and mitochondria [55,74]. 
There is a correlation between Akt accumulation in mitochondria and phosphorylation/inhibition 
of mitochondrial GSK3β in these organelles [5]. Yet, GSK3β prefers substrates that have been 
previously phosphorylated by another kinase. This preference for primed substrates provides a 
mean to integrate multiple signaling pathways within mitochondria. Although the role of GSK3β 
seems controversial, the majority of data suggests an important role for the phosphorylation of 
this enzyme in a cardioprotective scenario; for a review see [80]. 
The mitochondrial translocation of phospho-Akt is an important signal for cardioprotection and it 
is observed in different models of apoptosis prevention, including neuronal and cardiac cells, 
where activated Akt, besides GSK3β, may phosphorylate other mitochondrial proteins 
[1,5,50,55]. The importance of ERK1/2 in reperfusion in pre- and post-conditioning has been 
confirmed several times. For instance, Fryer et al. [28] reported rapid activation of ERK1/2 after 
pre-conditioning and then a second activation at 5 minutes of reperfusion, which was maintained 
after 30 and 60 minutes of reperfusion in the cytosolic and nuclear fractions. Yang et al. [87] and 
Darling et al. [22] reported that postconditioning resulted in an increase in phospho-ERK1/2 and 
consequent heart protection, which were abrogated by an inhibitor of ERK1/2. Although the 
activity of Akt in mitochondria is not well defined, the phosphorylation/activation of Akt is a 
pivotal event to induce cardioprotection. Accordingly, in I-PostC and in P-PostC phospho-Akt is 
significantly increased in the mitochondrial fraction (Fig 3). Moreover, here we report an 
increased mitochondria localization of phospho-ERK1/2 following I-PostC and P-PostC (Fig 4). 
While GSK3β phosphorylation/deactivation is reduced in I/R, its phosphorylation is similarly 
increased in the two cardioprotective protocols (Fig 5). Importantly, MPG reduces the levels of 
the phosphorylated forms of the three RISK elements induced by P-PostC in MF (Figs 3, 4 and 
5), thus supporting an intriguing role of the ROS-signaling in the activation/translocation of RISK 
by P-PostC. This is in line with the ROS signaling-dependent phosphorylation of RISK elements 
induced by I-PostC, with or without mitochondrial translocation of kinases [7,10,17,32,62]. 
SAFE: in I-PostC cardioprotection enhanced STAT3-phosphorylation and improved 
mitochondrial function have been confirmed in several species including pigs in vivo and in vitro 
[39,49]. The action of STAT3 on cardiac mitochondria and in particular on the inhibition of 
mPTP opening has been recently studied by Boengler et al. [8]. We confirm the presence of both 
Ser- and Tyr-phosphorylated STAT3 after I-PostC within mitochondria; however the lack of 
increase of phospho-STAT3 after the P-PostC with Diazoxide suggests that the SAFE pathway is 
a parallel pathway of RISK in I-PostC only. These two pathway can be activated simultaneously 
(I-PostC) and, perhaps, may cross-talk [34]. However, the SAFE pathway seems not necessary. In 
fact, the direct targeting of mitochondria by Diazoxide is protective, even though does not 
activate SAFE pathway (i.e., Diazoxide does not reverse the tendency in phospho-STAT3 
reduction induced by I/R). This is in line with the observation that mice lacking cardiac STAT3 
are still protected by I-PostC [34], though the number of postconditioning cycles is a critical 
factor to be considered for the successful effect of I-PostC in both aged and STAT3-deficient 
hearts [6]. Besides STAT3, also STAT5 activation has a cardioprotective role in humans [40] and 
the possibility of a vicariant protective effect of these two STATs deserves to be further studied. 
Signals of death: Importantly, either I-PostC or P-PostC maneuvers reduce the activation of 
signals of death caused by I/R. Both protocols, in fact, similarly preserve mitochondria integrity, 
as demonstrated by HSP60. Moreover, they also reduce cleaved caspase3, Beclin-1 and 
phosphorylation/translocation of PKCδ, which are implicated in all forms of cell death (apoptosis, 
autophagy and necrosis). Of note, it has been reported that increases in autophagic activity in the 
reperfusion phase are accompanied by upregulation of Beclin-1 in the heart [54]. Here we 
demonstrate that mitochondrial Beclin-1 is increased in I/R and that this increase is prevented by 
either I-PostC or P-PostC. However, the signaling mechanism by which I/R upregulates and 
PostC downregulates Beclin-1 expression is unknown. Notably, PKCδ may be a double-edged 
sword, though its phosphorylation more consistently triggers cell death [15,31,45,52,58]. Here we 
observe that I-PostC is more effective than P-PostC in reducing the phospho-PKCδ/total PKCδ 
ratio. Whether this difference is due to the lack of SAFE pathway activation in P-PostC needs to 
be determined. 
Mitochondrial translocation of proteins and limitation of the study: In all cells an important 
trafficking across cytosol and mitochondria is present. However, the mechanisms for kinase 
trafficking is only partially known [12,59]. Heat shock proteins and potential across the 
mitochondrial inner membrane may play an important role in mitochondrial import of specific 
protein [5,12]. Future studies should investigate the mechanisms of different trafficking in I-
PostC and P-PostC. In a recent review of Gucek & Murphy [29] it is reported that: “Elucidating 
the role of the mitochondria in cardioprotection will require a combination of examining 
candidate proteins as well as unbiased proteomic studies. The large-scale proteomics approach 
with the use of fractionation/enrichment is useful to identify unexpected protein changes. 
However, for low abundance signalling molecules, a targeted approach is necessary”. Here we 
report data collected with a “targeted approach”. Future proteomic and systems biology studies 
may analyze the mechanism of different mitochondrial protein import in cardioprotection. 
In conclusion, here we show the redox-sensitive localization of many phosphorylated RISK 
kinases into the mitochondria following both “classic” I-PostC and P-PostC with Diazoxide. 
However, while I-PostC also increased phosho-STAT3 within mitochondria, P-PostC does not. 
This suggests that signals upstream of mitochondria are required to activate SAFE pathway 
leading to STAT3 phosphorylation and subsequent mitochondrial localization [39]. Yet during the 
two cardioprotective protocols we observe an increased S-Nitrosylation of mitochondrial proteins, 
such as VDAC, which is considered an important signal of cardioprotection. In fact, both 
protocols down-regulate molecules, which can induce the death of cardiac cells. 
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Figure Legends 
Figure 1. Infarct size (IS).  
The amount of necrotic tissue is expressed as percent of the left ventricle (LV), which is 
considered the risk area. I/R: ischemia/reperfusion; I-PostC: ischemic postconditioning; P-
PostC: pharmacological postconditioning with Diazoxide; I-PostC+MPG: the antioxidant 
MPG was given during I-PostC maneuvers; P-PostC+MPG: MPG was co-infused with 
Diazoxide. **p < 0.01 and *p< 0.05 Vs. I/R. NS: not significant. 
 
 
Figure 2. Integrity and Purity of Isolated Mitochondria. 
A) Levels of HSP60 are used as indices of the integrity of mitochondria in non-ischemic 
(Sham), post-ischemic (I/R) and postconditioned (I-PostC and P-PostC) groups. Mean±SE of 
HSP60 levels in mitochondrial and cytosolic as well as HSP60 representative blots are 
reported. Data are expressed in arbitrary units (a.u.) and normalized for loading controls. 
*p<0.05 vs Sham. 
B) The presence of Na+/K+ ATPase, voltage-dependent anion-selective channel (VDAC), 
protein disulfide isomerase (PDI), Lamin A/C, Phospholamban (PLN) and Vinculin is used as 
index of the purity of mitochondria in Sham, I/R, I-PostC and P-PostC groups. Representative 
blots of bands from mitochondrial and cytosolic fractions are reported. 
 
 
 
 
Figure 3. Mitochondrial Akt.  
Levels of total and phosphorylated Akt (phospho-Akt) have been analyzed in Sham, I/R, I-
PostC, P-PostC, Sham+MPG and P-PostC+MPG groups. Mean±SE of the relative phospho-
Akt/total Akt ratio in mitochondrial fraction and their representative blots are reported. Data 
are normalized for loading control (HADHA) and then with respect to mean value of Sham 
group. *p<0.05 vs Sham; # p< 0.05 vs I/R. NS: not significant. 
 
 
Figure 4 Mitochondrial ERK1/2.  
Levels of total and phosphorylated ERK1/2 (phospho-ERK1/2) have been analyzed in Sham, 
I/R, I-PostC, P-PostC groups, Sham+MPG and P-PostC+MPG groups. Mean±SE of the 
relative phospho-ERK1/2/total ERK1/2 ratio in mitochondrial fraction and their representative 
blots are reported. Data are normalized for loading control (HADHA) and then with respect to 
mean value of Sham group. *p<0.05 vs Sham; # p< 0.05 vs I/R. NS: not significant. 
 
 
Figure 5. Mitochondrial GSK3β.  
Levels of total and phosphorylated GSK3β (phospho- GSK3β) have been analyzed in Sham, 
I/R, I-PostC, P-PostC, Sham+MPG and P-PostC+MPG groups. Mean±SE of the relative 
phospho-GSK3β/total GSK3β ratio in mitochondrial fraction and their representative blots are 
reported. Data are normalized for loading control (HADHA) and then with respect to mean 
value of Sham group. *p<0.05 vs Sham; # p< 0.05 vs I/R. NS: not significant. 
 
Figure 6. Mitochondrial p-Ser-STAT3.  
Levels of total and phosphorylated in Ser-STAT3 (p-Ser-STAT3) and in Tyr-STAT3 (p-Tyr-
STAT3) have been analyzed in I/R, I-PostC and P-PostC groups. Mean±SE of the relative 
phospho-STAT3/total STAT3 ratio (for both sites of phosphorylation) in mitochondrial 
fraction and their representative blots are reported. Data are normalized for loading control 
(HADHA) and then with respect to mean value of Sham group. **p<0.01 vs Sham; ## p< 
0.05 vs I/R.  
 
 
Figure 7. S-Nitrosylation (SNO) of Mitochondrial Proteins.  
Levels of total SNO proteins have been analyzed by biotin switch assay in the mitochondrial 
fraction of the Sham, Sham+DZO, I/R, I-PostC and P-PostC groups. To verify the specificity 
of the biotin switch assay, ascorbate has been omitted in Sham samples (-Asc). The analysis 
of total bands shows an increase in S-Nitrosylation in I-PostC and P-PostC as well as in 
Sham+DZO. Mean±SE of the levels of SNO proteins in mitochondrial fraction and their 
representative blots are reported. Data are reported as normalized arbitrary units (a.u.). 
Specific protein analysis shows an increased SNO of VDAC in I-PostC, P-PostC and in 
Sham+DZO. *p<0.05 vs Sham; # p< 0.05 vs I/R. **p<0.05 vs Sham; ## p< 0.05 vs I/R. NS: 
not significant. 
 
 
 
Figure 8. Death Signals.  
A and B) Cytosolic and Mitochondrial PKCδ. Levels of total and phosphorylated PKCδ (p-
PKCδ) have been analyzed in non-ischemic (Sham), post-ischemic (I/R) and postconditioned 
(I-PostC and P-PostC) groups in both in cytosolic and mitochondrial fractions. Presented 
bands were not juxtaposed in the original film. Data are normalized for loading control 
(vinculin or HADHA) and then with respect to mean value of Sham group. Mean±SE of the 
relative phospho-PKCδ/total PKCδ ratio in mitochondrial and cytosolic fraction and their 
representative blots are reported. **p<0.01 vs all other groups; # p< 0.05 vs I/R. 
C) Cytosolic cleaved-caspase-3. Levels of cleaved-caspase-3 have been analyzed in the 
cytosolic fraction of the four experimental groups (Sham, I/R, I-PostC and P-PostC groups). 
Data are normalized for loading control (vinculin) and then with respect to mean value of 
Sham group. Mean±SE in cytosolic fraction and their representative blots are reported. 
**p<0.01 vs all other groups 
D) Mitochondrial Beclin-1. Levels of Beclin-1 have been analyzed in the mitochondrial 
fraction of the four experimental groups (Sham, I/R, I-PostC and P-PostC groups). Data are 
normalized for loading control (HADHA) and then with respect to mean value of Sham group. 
Mean±SE in cytosolic fraction and their representative blots are reported. **p<0.01 vs all 
other groups. 
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